title: Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.
authors.forename: Antonella
authors.initials: A
authors.lastname: Vitale
authors.forename: Sara
authors.initials: S
authors.lastname: Grammatico
authors.forename: Saveria
authors.initials: S
authors.lastname: Capria
authors.forename: Carina
authors.initials: C
authors.lastname: Fiocchi
authors.forename: Robin
authors.initials: R
authors.lastname: Foà
authors.forename: Giovanna
authors.initials: G
authors.lastname: Meloni
mesh_terms: D000227:Adenine Nucleotides / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001087:Arabinonucleosides / Q000008:administration & dosage; D000077866:Clofarabine; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D047428:Protein Kinase Inhibitors; D000077866:Clofarabine; D003520:Cyclophosphamide